23andMe Fails to Turn DNA Data into Medicines and Care
23andMe entered the scene by collecting saliva samples from millions of customers and providing ancestry results. However, the company aimed to expand its services to develop new medicines and offer personalized healthcare. It hoped its vast genetic data would aid research. Despite this goal, 23andMe struggled. The company’s efforts to become a biotechnology firm and … Read more